Skånes Universitetssjukhus, Lund
- Address
- Kioskgatan 5, Reumatologimottagning Lund, 22185 Lund, Sweden
Skånes Universitetssjukhus, Lund - Rheumatology Research Center
Skånes Universitetssjukhus in Lund serves as a leading research institution specializing in the investigation and treatment of rheumatoid arthritis, with particular emphasis on early disease intervention and therapeutic optimization. The center demonstrates expertise in conducting complex comparative effectiveness studies that evaluate multiple treatment approaches in autoimmune rheumatic diseases.
- Early rheumatoid arthritis treatment strategies and remission achievement
- Comparative effectiveness research of biologic versus conventional therapies
- Treatment de-escalation protocols and long-term disease management
The research program at Skånes Universitetssjukhus focuses on large-scale, multicenter trials that employ rigorous blinded-assessor methodologies to compare active conventional therapy against advanced biologic treatments. Their work is particularly significant in developing evidence-based strategies for therapy de-escalation in patients who achieve treatment response, ultimately contributing to personalized medicine approaches in rheumatoid arthritis management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Karolinska Institutet1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Skånes Universitetssjukhus, Lund
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 4 Multicenter Study Comparing Active Conventional Therapy with Biologic Agents and De-escalation Strategies in Early Rheumatoid Arthritis | Karolinska Institutet | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abatacept | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.